FDA Orange Book
Is there a generic for Veppanu?
Veppanu contains vepdegestrant. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Veppanu (vepdegestrant). The Orange Book shows its last listed patent expires January 30, 2038 and its last listed exclusivity ends May 1, 2031.
Run it in Rivvi
Map Veppanu and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Veppanu products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | 100MG | Marketed (Rx) | None | 0 | None |
| tablet, oral | 200MG | Marketed (Rx) | None | 0 | None |
NDA 219835, held by RIGEL PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Veppanu patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 11597720 | December 1, 2037 | Drug substance, Drug product | U-4278 | 219835 |
| 10899742 | December 1, 2037 | Method of use | U-4278 | 219835 |
| 10647698 | January 30, 2038 | Drug substance, Drug product | None | 219835 |
Veppanu exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | May 1, 2031 | 219835 |
Veppanu NDC codes
Questions
Is there a generic for Veppanu?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Veppanu (vepdegestrant). The Orange Book shows its last listed patent expires January 30, 2038 and its last listed exclusivity ends May 1, 2031.
What is the generic name for Veppanu?
The active ingredient in Veppanu is vepdegestrant, per the FDA Orange Book.
When does the Veppanu patent expire?
The last patent listed for Veppanu in the Orange Book expires January 30, 2038. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.